Search Filters
Advanced Search
SMC ID Date Medicine Submission Type Indication
SMC2273 07/09/2020 andexanet alfa (Ondexxya) Full

For adult patients treated with a direct factor Xa (FXa) inhibitor (apixaban or rivaroxaban) when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
1029/15 09/03/2015 apixaban (Eliquis) Full Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE in adults.
836/13 11/02/2013 apixaban (Eliquis) Full For the prevention of stroke and systemic embolism (SE) in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors such as prior stroke or transient ischaemic attack(TIA): age ≥75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYYA Class ≥ II).
741/11 12/12/2011 apixaban (Eliquis) Full For the treatment of venous thromboembolic events (VTE) in adult patients who have undergone elective hip (THR) or knee (TKR) replacement surgery.

No medicines have been found